SC
AORT icon

SummitTX Capital’s Artivion AORT Stock Holding History

SummitTX Capital’s Portfolio AORT Stock Details AORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$250K Buy
+11,126
New +$311K 0.01% 697

Other funds holding AORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

SummitTX Capital's AORT Position: Q2 2026 in Review

SummitTX Capital opened a new position in Artivion (AORT) in Q2 2026: 11,126 shares worth $250K. The stake represents 0.01% of the portfolio and ranks #697 among its holdings.

206 funds tracked by Wall St. Rank hold AORT as of Q2 2026.

  • SummitTX Capital held 11,126 shares of Artivion worth $250K as of Q2 2026.
  • Artivion was a new SummitTX Capital position in Q2 2026.
  • Artivion made up 0.01% of SummitTX Capital's portfolio in Q2 2026, its #697 holding.
  • 206 funds tracked by Wall St. Rank held Artivion as of Q2 2026.

Based on SummitTX Capital's 13F filing for Q2 2026, filed 14 Aug 2026.